/Investor DB

Sonder Capital — 2023 Investments

3 investments dated 2023 · listed companies and verified rows first · show all

Mendaeramendaera.comin𝕏Series A · Aug 2023 · $24M

Mendaera builds robotic technology, including its Focalist System for robotic-guided access and procedures such as transplant biopsy, to help healthcare providers perform reproducible clinical procedures.

Digital HealthHealthtechMedical DevicesRoboticsSan Mateo, US

Josh DeFonzo(Founder)inJason Wilson(Founder)

Co-investorsThreshold VenturesFounders FundLux CapitalAverin CapitalFemHealth VenturesGaingels+4 more

Neuro42neuro42.aiinOct 2023

neuro42 develops a portable, FDA 510(k)-cleared MRI platform that brings neurological imaging directly to the patient rather than requiring transport to a facility.

Deep TechHealthtechMedical DevicesSan Francisco, US

Amit Vohra(Executive Officer, Director)inAbhita Batra(Executive Officer, Director)Shibu Gangadharan(Executive Officer)

BoardKrishna R. Bhupal(Director)Rahul Talwar(Director)

Co-investorsFrontier Path VCShangBay Capital LLC

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

BruxA

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.